CN104548212A - 一种促进牙髓及牙本质再生的组合物 - Google Patents
一种促进牙髓及牙本质再生的组合物 Download PDFInfo
- Publication number
- CN104548212A CN104548212A CN201410841688.6A CN201410841688A CN104548212A CN 104548212 A CN104548212 A CN 104548212A CN 201410841688 A CN201410841688 A CN 201410841688A CN 104548212 A CN104548212 A CN 104548212A
- Authority
- CN
- China
- Prior art keywords
- pdgf
- root
- dental pulp
- compositions
- growth factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 71
- 210000003074 dental pulp Anatomy 0.000 title claims abstract description 40
- 230000008929 regeneration Effects 0.000 title claims abstract description 35
- 238000011069 regeneration method Methods 0.000 title claims abstract description 35
- 210000004268 dentin Anatomy 0.000 title claims abstract description 30
- 230000001737 promoting effect Effects 0.000 title abstract description 9
- 108010081589 Becaplermin Proteins 0.000 claims abstract description 48
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims abstract description 47
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims abstract description 47
- 108010049003 Fibrinogen Proteins 0.000 claims abstract description 29
- 102000008946 Fibrinogen Human genes 0.000 claims abstract description 29
- 229940012952 fibrinogen Drugs 0.000 claims abstract description 29
- 210000004262 dental pulp cavity Anatomy 0.000 claims abstract description 21
- 229920001661 Chitosan Polymers 0.000 claims abstract description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 9
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 6
- 102000008186 Collagen Human genes 0.000 claims abstract description 6
- 108010035532 Collagen Proteins 0.000 claims abstract description 6
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 6
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 108010000685 platelet-derived growth factor AB Proteins 0.000 claims abstract description 5
- 229920002101 Chitin Polymers 0.000 claims abstract description 4
- 108010010803 Gelatin Proteins 0.000 claims abstract description 4
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 4
- 229920000615 alginic acid Polymers 0.000 claims abstract description 4
- 239000008273 gelatin Substances 0.000 claims abstract description 4
- 229920000159 gelatin Polymers 0.000 claims abstract description 4
- 235000019322 gelatine Nutrition 0.000 claims abstract description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 4
- 108010017843 platelet-derived growth factor A Proteins 0.000 claims abstract description 4
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims abstract description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims abstract description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims abstract description 3
- 229920001287 Chondroitin sulfate Polymers 0.000 claims abstract description 3
- 229920001503 Glucan Polymers 0.000 claims abstract description 3
- 229920002527 Glycogen Polymers 0.000 claims abstract description 3
- 229920002907 Guar gum Polymers 0.000 claims abstract description 3
- 108010076876 Keratins Proteins 0.000 claims abstract description 3
- 102000011782 Keratins Human genes 0.000 claims abstract description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims abstract description 3
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229920002472 Starch Polymers 0.000 claims abstract description 3
- 235000010489 acacia gum Nutrition 0.000 claims abstract description 3
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims abstract description 3
- 229940072056 alginate Drugs 0.000 claims abstract description 3
- 229940059329 chondroitin sulfate Drugs 0.000 claims abstract description 3
- 229920001436 collagen Polymers 0.000 claims abstract description 3
- 229960005188 collagen Drugs 0.000 claims abstract description 3
- 229940014259 gelatin Drugs 0.000 claims abstract description 3
- 229940096919 glycogen Drugs 0.000 claims abstract description 3
- 239000000665 guar gum Substances 0.000 claims abstract description 3
- 235000010417 guar gum Nutrition 0.000 claims abstract description 3
- 229960002154 guar gum Drugs 0.000 claims abstract description 3
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 3
- 239000004310 lactic acid Substances 0.000 claims abstract description 3
- 229960000448 lactic acid Drugs 0.000 claims abstract description 3
- 229960000502 poloxamer Drugs 0.000 claims abstract description 3
- 229920001983 poloxamer Polymers 0.000 claims abstract description 3
- 239000000843 powder Substances 0.000 claims abstract description 3
- 229960002901 sodium glycerophosphate Drugs 0.000 claims abstract description 3
- REULQIKBNNDNDX-UHFFFAOYSA-M sodium;2,3-dihydroxypropyl hydrogen phosphate Chemical compound [Na+].OCC(O)COP(O)([O-])=O REULQIKBNNDNDX-UHFFFAOYSA-M 0.000 claims abstract description 3
- 239000008107 starch Substances 0.000 claims abstract description 3
- 235000019698 starch Nutrition 0.000 claims abstract description 3
- 229940032147 starch Drugs 0.000 claims abstract description 3
- 239000003894 surgical glue Substances 0.000 claims abstract description 3
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 3
- 239000000230 xanthan gum Substances 0.000 claims abstract description 3
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 3
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 3
- 239000000463 material Substances 0.000 claims description 57
- 108090000190 Thrombin Proteins 0.000 claims description 35
- 229960004072 thrombin Drugs 0.000 claims description 35
- 108010073385 Fibrin Proteins 0.000 claims description 32
- 102000009123 Fibrin Human genes 0.000 claims description 32
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 32
- 229950003499 fibrin Drugs 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 20
- 239000000499 gel Substances 0.000 claims description 14
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 241000124008 Mammalia Species 0.000 claims description 5
- -1 natural clot Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000003786 synthesis reaction Methods 0.000 claims description 4
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- 150000002337 glycosamines Chemical class 0.000 claims description 2
- 102000057593 human F8 Human genes 0.000 claims description 2
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 2
- 229940047431 recombinate Drugs 0.000 claims description 2
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 abstract description 18
- 230000008439 repair process Effects 0.000 abstract description 8
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 abstract 1
- 229960002442 glucosamine Drugs 0.000 abstract 1
- 239000003106 tissue adhesive Substances 0.000 abstract 1
- 239000000084 colloidal system Substances 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 15
- 208000032843 Hemorrhage Diseases 0.000 description 12
- 238000010586 diagram Methods 0.000 description 11
- 239000003292 glue Substances 0.000 description 10
- 230000023555 blood coagulation Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 230000004071 biological effect Effects 0.000 description 5
- 239000007943 implant Substances 0.000 description 5
- 238000012856 packing Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 239000003462 bioceramic Substances 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 239000012531 culture fluid Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- 239000000899 Gutta-Percha Substances 0.000 description 3
- 240000000342 Palaquium gutta Species 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000035605 chemotaxis Effects 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 229920000588 gutta-percha Polymers 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000000693 micelle Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 102000007325 Amelogenin Human genes 0.000 description 2
- 108010007570 Amelogenin Proteins 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 230000002301 combined effect Effects 0.000 description 2
- 208000007147 dental pulp necrosis Diseases 0.000 description 2
- 210000005258 dental pulp stem cell Anatomy 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- ADVGKWPZRIDURE-UHFFFAOYSA-N 2'-Hydroxyacetanilide Chemical compound CC(=O)NC1=CC=CC=C1O ADVGKWPZRIDURE-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 1
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 1
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 102100037362 Fibronectin Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 1
- 102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
- 101000990915 Homo sapiens Stromelysin-1 Proteins 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
- 102100020880 Kit ligand Human genes 0.000 description 1
- 101710177504 Kit ligand Proteins 0.000 description 1
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 description 1
- 101001055320 Myxine glutinosa Insulin-like growth factor Proteins 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010028916 Neologism Diseases 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000015336 Nerve Growth Factor Human genes 0.000 description 1
- 101800003845 Neuropeptide Y Proteins 0.000 description 1
- 102400000064 Neuropeptide Y Human genes 0.000 description 1
- 102000004230 Neurotrophin 3 Human genes 0.000 description 1
- 108090000742 Neurotrophin 3 Proteins 0.000 description 1
- 229920001244 Poly(D,L-lactide) Polymers 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 101710088580 Stromal cell-derived factor 1 Proteins 0.000 description 1
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 1
- 102100030416 Stromelysin-1 Human genes 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 208000008010 Tooth Avulsion Diseases 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
- 229960004099 azithromycin Drugs 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229960000590 celecoxib Drugs 0.000 description 1
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000012412 chemical coupling Methods 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 229960004752 ketorolac Drugs 0.000 description 1
- OZWKMVRBQXNZKK-UHFFFAOYSA-N ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 229960003464 mefenamic acid Drugs 0.000 description 1
- HYYBABOKPJLUIN-UHFFFAOYSA-N mefenamic acid Chemical compound CC1=CC=CC(NC=2C(=CC=CC=2)C(O)=O)=C1C HYYBABOKPJLUIN-UHFFFAOYSA-N 0.000 description 1
- 229960001929 meloxicam Drugs 0.000 description 1
- 230000000921 morphogenic effect Effects 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 229940032018 neurotrophin 3 Drugs 0.000 description 1
- 229960000965 nimesulide Drugs 0.000 description 1
- HYWYRSMBCFDLJT-UHFFFAOYSA-N nimesulide Chemical compound CS(=O)(=O)NC1=CC=C([N+]([O-])=O)C=C1OC1=CC=CC=C1 HYWYRSMBCFDLJT-UHFFFAOYSA-N 0.000 description 1
- 230000032724 odontogenesis Effects 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229960000371 rofecoxib Drugs 0.000 description 1
- RZJQGNCSTQAWON-UHFFFAOYSA-N rofecoxib Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=C(C=2C=CC=CC=2)C(=O)OC1 RZJQGNCSTQAWON-UHFFFAOYSA-N 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
Landscapes
- Dental Preparations (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410841688.6A CN104548212B (zh) | 2014-12-31 | 2014-12-31 | 一种促进牙髓及牙本质再生的组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410841688.6A CN104548212B (zh) | 2014-12-31 | 2014-12-31 | 一种促进牙髓及牙本质再生的组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104548212A true CN104548212A (zh) | 2015-04-29 |
CN104548212B CN104548212B (zh) | 2018-05-11 |
Family
ID=53065974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410841688.6A Expired - Fee Related CN104548212B (zh) | 2014-12-31 | 2014-12-31 | 一种促进牙髓及牙本质再生的组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104548212B (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105963800A (zh) * | 2016-06-27 | 2016-09-28 | 林春梅 | 一种医用支架材料及其制备方法 |
CN110075126A (zh) * | 2019-05-08 | 2019-08-02 | 张永国 | 一种牙龈细胞水凝胶填充剂及其制备方法、应用 |
WO2019183201A1 (en) * | 2018-03-20 | 2019-09-26 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Regeneration of vital tooth pulp |
CN110664993A (zh) * | 2019-10-22 | 2020-01-10 | 南方医科大学南方医院 | 纤维蛋白原γ链在牙齿再生领域的新用途及其试剂盒 |
CN111148536A (zh) * | 2017-09-29 | 2020-05-12 | 国立研究开发法人国立长寿医疗研究中心 | 非细胞根管填料以及非细胞牙体组织再生促进试剂盒 |
CN112891630A (zh) * | 2021-01-27 | 2021-06-04 | 苏州大学 | 一种用于骨修复的可植入血块凝胶组合物及其制备方法 |
CN113318274A (zh) * | 2021-05-31 | 2021-08-31 | 重庆医科大学附属口腔医院 | 一种水凝胶及其制备方法和应用 |
CN113730651A (zh) * | 2020-12-21 | 2021-12-03 | 刘永兴 | 一种用于促进骨再生的生物材料、制备方法及应用 |
IT202100024257A1 (it) * | 2021-09-21 | 2023-03-21 | Univ Degli Studi Di Torino | Preparazione odontostomatologica comprendente acido ialuronico e antibiotici |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101198343A (zh) * | 2004-10-14 | 2008-06-11 | 生物模拟治疗公司 | 血小板衍生生长因子组合物及其使用方法 |
CN101772350A (zh) * | 2007-06-19 | 2010-07-07 | 巴克斯特国际公司 | 用于pdgf受控释放的纤维蛋白凝胶及其应用 |
CN102639081A (zh) * | 2009-06-17 | 2012-08-15 | 纽约市哥伦比亚大学信托人 | 牙齿支架 |
CN103210081A (zh) * | 2010-10-01 | 2013-07-17 | 纽约市哥伦比亚大学理事会 | Pdgf 诱导的细胞归巢 |
CN104000737A (zh) * | 2014-06-10 | 2014-08-27 | 上海交通大学医学院附属第九人民医院 | 一种组织工程化牙髓-牙本质复合体 |
WO2014153548A1 (en) * | 2013-03-21 | 2014-09-25 | The Trustees Of Columbia University In The City Of New York | Compositions and methods for dental tissue regeneration |
-
2014
- 2014-12-31 CN CN201410841688.6A patent/CN104548212B/zh not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101198343A (zh) * | 2004-10-14 | 2008-06-11 | 生物模拟治疗公司 | 血小板衍生生长因子组合物及其使用方法 |
CN101772350A (zh) * | 2007-06-19 | 2010-07-07 | 巴克斯特国际公司 | 用于pdgf受控释放的纤维蛋白凝胶及其应用 |
CN102639081A (zh) * | 2009-06-17 | 2012-08-15 | 纽约市哥伦比亚大学信托人 | 牙齿支架 |
CN103210081A (zh) * | 2010-10-01 | 2013-07-17 | 纽约市哥伦比亚大学理事会 | Pdgf 诱导的细胞归巢 |
WO2014153548A1 (en) * | 2013-03-21 | 2014-09-25 | The Trustees Of Columbia University In The City Of New York | Compositions and methods for dental tissue regeneration |
CN104000737A (zh) * | 2014-06-10 | 2014-08-27 | 上海交通大学医学院附属第九人民医院 | 一种组织工程化牙髓-牙本质复合体 |
Non-Patent Citations (1)
Title |
---|
路博闻等: "牙周组织工程研究进展:问题与应用", 《中国组织工程研究》 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105963800A (zh) * | 2016-06-27 | 2016-09-28 | 林春梅 | 一种医用支架材料及其制备方法 |
CN111148536A (zh) * | 2017-09-29 | 2020-05-12 | 国立研究开发法人国立长寿医疗研究中心 | 非细胞根管填料以及非细胞牙体组织再生促进试剂盒 |
CN111148536B (zh) * | 2017-09-29 | 2021-12-28 | 兴和株式会社 | 非细胞根管填料以及非细胞牙体组织再生促进试剂盒 |
WO2019183201A1 (en) * | 2018-03-20 | 2019-09-26 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Regeneration of vital tooth pulp |
CN110075126A (zh) * | 2019-05-08 | 2019-08-02 | 张永国 | 一种牙龈细胞水凝胶填充剂及其制备方法、应用 |
CN110664993A (zh) * | 2019-10-22 | 2020-01-10 | 南方医科大学南方医院 | 纤维蛋白原γ链在牙齿再生领域的新用途及其试剂盒 |
CN113730651A (zh) * | 2020-12-21 | 2021-12-03 | 刘永兴 | 一种用于促进骨再生的生物材料、制备方法及应用 |
CN112891630A (zh) * | 2021-01-27 | 2021-06-04 | 苏州大学 | 一种用于骨修复的可植入血块凝胶组合物及其制备方法 |
CN113318274A (zh) * | 2021-05-31 | 2021-08-31 | 重庆医科大学附属口腔医院 | 一种水凝胶及其制备方法和应用 |
CN113318274B (zh) * | 2021-05-31 | 2022-10-14 | 重庆医科大学附属口腔医院 | 一种水凝胶及其制备方法和应用 |
IT202100024257A1 (it) * | 2021-09-21 | 2023-03-21 | Univ Degli Studi Di Torino | Preparazione odontostomatologica comprendente acido ialuronico e antibiotici |
WO2023047297A1 (en) * | 2021-09-21 | 2023-03-30 | Universita' Degli Studi Di Torino | Odontostomatological preparation comprising hyaluronic acid, antibiotics and growth factors |
Also Published As
Publication number | Publication date |
---|---|
CN104548212B (zh) | 2018-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104548212A (zh) | 一种促进牙髓及牙本质再生的组合物 | |
Tahmasebi et al. | Current biocompatible materials in oral regeneration: a comprehensive overview of composite materials | |
Moussa et al. | Present and future of tissue engineering scaffolds for dentin‐pulp complex regeneration | |
Wang et al. | Collagen-based biomaterials for tissue engineering | |
Raddall et al. | Biomaterials and scaffold design strategies for regenerative endodontic therapy | |
Nelson et al. | Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges | |
Orti et al. | Pulp regeneration concepts for nonvital teeth: from tissue engineering to clinical approaches | |
Li et al. | Pulp regeneration in a full-length human tooth root using a hierarchical nanofibrous microsphere system | |
Zhao et al. | Osteogenic media and rhBMP-2-induced differentiation of umbilical cord mesenchymal stem cells encapsulated in alginate microbeads and integrated in an injectable calcium phosphate-chitosan fibrous scaffold | |
ES2791769T3 (es) | Espumas de fibroína de seda inyectables y usos de la misma | |
Zhao et al. | An injectable calcium phosphate-alginate hydrogel-umbilical cord mesenchymal stem cell paste for bone tissue engineering | |
Galler et al. | A customized self-assembling peptide hydrogel for dental pulp tissue engineering | |
JP5002816B2 (ja) | 移植材料及び骨質改善剤 | |
Mozafari et al. | Nanoengineered biomaterials for regenerative medicine | |
Liu et al. | Advances of adipose-derived mesenchymal stem cells-based biomaterial scaffolds for oral and maxillofacial tissue engineering | |
Galli et al. | Current and future trends in periodontal tissue engineering and bone regeneration | |
Saltz et al. | Mesenchymal stem cells and alginate microcarriers for craniofacial bone tissue engineering: A review | |
Chen et al. | Gas-foaming calcium phosphate cement scaffold encapsulating human umbilical cord stem cells | |
US20160354518A1 (en) | Bone pastes comprising biofunctionalized calcium phosphate cements with enhanced cell functions for bone repair | |
Zhou et al. | Biofunctionalized calcium phosphate cement to enhance the attachment and osteodifferentiation of stem cells released from fast-degradable alginate-fibrin microbeads | |
Liu et al. | Biomaterial scaffolds for clinical procedures in endodontic regeneration | |
CN102120033A (zh) | 促口腔额面部多种创伤修复的复合生长因子的胶原蛋白缓释载体材料及其制备方法 | |
Mehrotra et al. | From injectable to 3D printed hydrogels in maxillofacial tissue engineering: A review | |
Li et al. | Injectable thermosensitive chitosan/gelatin-based hydrogel carried erythropoietin to effectively enhance maxillary sinus floor augmentation in vivo | |
Yi et al. | Utilizing 3D bioprinted platelet-rich fibrin-based materials to promote the regeneration of oral soft tissue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160317 Address after: Suzhou City, Jiangsu Province, Suzhou Industrial Park 215123 Xinghu Street No. 218 BioBAY A1 North Building 2 floor E130 unit Applicant after: The new colvo regenerative medicine (Suzhou) Co.,Ltd. Address before: 430000 Hubei Province, Wuhan East Lake Development Zone high-tech road No. 666 Wuhan national biological industry base project B, C, D & B1 building area Applicant before: WUHAN RENZHIYUAN STEM CELL TECHNOLOGY Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180511 |
|
CF01 | Termination of patent right due to non-payment of annual fee |